Nanjing Pharmaceutical Co Ltd Class A 600713
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥4.60
- Day Range
- ¥4.60–4.70
- 52-Week Range
- ¥3.85–5.63
- Bid/Ask
- ¥4.67 / ¥4.68
- Market Cap
- ¥6.13 Bil
- Volume/Avg
- 13.5 Mil / 6.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 10.28
- Price/Sales
- 0.11
- Dividend Yield (Trailing)
- 3.42%
- Dividend Yield (Forward)
- 3.42%
- Total Yield
- 3.42%
Company Profile
Nanjing Pharmaceutical Co Ltd is engaged in the pharmaceutical service business.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Mid Value
- Total Number of Employees
- 4,903
- Website
- http://www.guangyuyuan.com
Comparables
Valuation
|
Metric
|
600713
|
000919
|
603896
|
|---|---|---|---|
Price/Earnings (Normalized) | 10.28 | 58.45 | 18.81 |
Price/Book Value | 0.94 | 1.07 | 2.05 |
Price/Sales | 0.11 | 1.20 | 5.76 |
Price/Cash Flow | 4.26 | 15.61 | 12.20 |
Price/Earnings
600713
000919
603896
Financial Strength
|
Metric
|
600713
|
000919
|
603896
|
|---|---|---|---|
Quick Ratio | 1.09 | 3.28 | 3.21 |
Current Ratio | 1.44 | 3.61 | 3.70 |
Interest Coverage | 4.34 | 388.44 | 16.62 |
Quick Ratio
600713
000919
603896
Profitability
|
Metric
|
600713
|
000919
|
603896
|
|---|---|---|---|
Return on Assets (Normalized) | 2.45% | 1.25% | 7.55% |
Return on Equity (Normalized) | 11.96% | 1.83% | 11.00% |
Return on Invested Capital (Normalized) | 6.16% | 1.04% | 7.10% |
Return on Assets
600713
000919
603896
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Lqfshdvwhk | Gwlb | $790.4 Bil | |||
| Johnson & Johnson
JNJ
| Yldktdqw | Ryxpj | $388.5 Bil | |||
| AbbVie Inc
ABBV
| Gsxbwcbmn | Qxftc | $344.1 Bil | |||
| Merck & Co Inc
MRK
| Qfqqlkrcp | Sdfk | $288.2 Bil | |||
| Roche Holding AG ADR
RHHBY
| Ltdfvtyjj | Yyy | $258.7 Bil | |||
| AstraZeneca PLC ADR
AZN
| Cnvwxtqfr | Qjyx | $242.3 Bil | |||
| Novartis AG ADR
NVS
| Bytkpxd | Zvsz | $234.2 Bil | |||
| Amgen Inc
AMGN
| Ylvgvxbhn | Wdl | $173.4 Bil | |||
| Pfizer Inc
PFE
| Tflfhkzw | Xbd | $164.8 Bil | |||
| Sanofi SA ADR
SNY
| Cxyvrtyks | Thn | $144.3 Bil |
United States